Literature DB >> 17663687

Unrelated cord blood transplantation in children with sickle cell disease: review of four-center experience.

Tom V Adamkiewicz1, Paul Szabolcs, Ann Haight, K Scott Baker, Susan Staba, Amos Kedar, K Y Chiang, Lakshmanan Krishnamurti, Michael W Boyer, Joan Kurtzberg, John E Wagner, John R Wingard, Andrew M Yeager.   

Abstract

UCBT was performed in seven children with SCD and stroke (HLA match 4/6 n=5; 5/6 n=2). Four received myeloablative regimens (BU, CY, ATG plus FLU in one patient). One had primary graft failure, three had sustained engraftment, two with grade III-IV GVHD (one died, one developed chronic GVHD), one with stable mixed chimerism. Three patients treated with reduced-intensity regimens (FLU, BU or CY, ATG, TLI) failed to engraft; one engrafted after second UCBT (HU, TT, RXA, ALZ, TBI). Four patients (57%) developed viral infections. Engraftment, GVHD, and infection remain challenges.

Entities:  

Mesh:

Year:  2007        PMID: 17663687     DOI: 10.1111/j.1399-3046.2007.00725.x

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  18 in total

1.  Umbilical cord blood transplantation for children with thalassemia and sickle cell disease.

Authors:  Annalisa Ruggeri; Mary Eapen; Andromachi Scaravadou; Mitchell S Cairo; Monica Bhatia; Joanne Kurtzberg; John R Wingard; Anders Fasth; Luca Lo Nigro; Mouhab Ayas; Duncan Purtill; Karim Boudjedir; Wagnara Chaves; Mark C Walters; John Wagner; Eliane Gluckman; Vanderson Rocha
Journal:  Biol Blood Marrow Transplant       Date:  2011-01-28       Impact factor: 5.742

2.  Future alternative therapies for β-thalassemia.

Authors:  Stefano Rivella; Eliezer Rachmilewitz
Journal:  Expert Rev Hematol       Date:  2009-12-01       Impact factor: 2.929

Review 3.  Alternative donor transplant of benign primary hematologic disorders.

Authors:  J Tolar; P Sodani; H Symons
Journal:  Bone Marrow Transplant       Date:  2015-02-09       Impact factor: 5.483

4.  Unrelated donor cord blood transplantation for children with severe sickle cell disease: results of one cohort from the phase II study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN).

Authors:  Naynesh R Kamani; Mark C Walters; Shelly Carter; Victor Aquino; Joel A Brochstein; Sonali Chaudhury; Mary Eapen; Brian M Freed; Michael Grimley; John E Levine; Brent Logan; Theodore Moore; Julie Panepinto; Suhag Parikh; Michael A Pulsipher; Jane Sande; Kirk R Schultz; Stephen Spellman; Shalini Shenoy
Journal:  Biol Blood Marrow Transplant       Date:  2012-02-16       Impact factor: 5.742

Review 5.  Hematopoietic stem cell transplantation for patients with sickle cell disease: progress and future directions.

Authors:  Courtney D Fitzhugh; Allistair A Abraham; John F Tisdale; Matthew M Hsieh
Journal:  Hematol Oncol Clin North Am       Date:  2014-09-29       Impact factor: 3.722

Review 6.  Allogeneic hematopoietic stem cell transplantation for sickle cell disease: the time is now.

Authors:  Matthew M Hsieh; Courtney D Fitzhugh; John F Tisdale
Journal:  Blood       Date:  2011-05-31       Impact factor: 22.113

Review 7.  Umbilical cord blood: an evolving stem cell source for sickle cell disease transplants.

Authors:  Shalini Shenoy
Journal:  Stem Cells Transl Med       Date:  2013-04-11       Impact factor: 6.940

8.  A novel reduced-intensity conditioning regimen for unrelated umbilical cord blood transplantation in children with nonmalignant diseases.

Authors:  Suhag H Parikh; Adam Mendizabal; Cara L Benjamin; Krishna V Komanduri; Jeyaraj Antony; Aleksandra Petrovic; Gregory Hale; Timothy A Driscoll; Paul L Martin; Kristin M Page; Ketti Flickinger; Jerelyn Moffet; Donna Niedzwiecki; Joanne Kurtzberg; Paul Szabolcs
Journal:  Biol Blood Marrow Transplant       Date:  2013-12-01       Impact factor: 5.742

9.  Reduced intensity HLA-haploidentical BMT with post transplantation cyclophosphamide in nonmalignant hematologic diseases.

Authors:  R A Brodsky; L Luznik; J Bolaños-Meade; M S Leffell; R J Jones; E J Fuchs
Journal:  Bone Marrow Transplant       Date:  2008-07-14       Impact factor: 5.483

Review 10.  Blood and marrow transplantation for sickle cell disease: overcoming barriers to success.

Authors:  Javier Bolaños-Meade; Robert A Brodsky
Journal:  Curr Opin Oncol       Date:  2009-03       Impact factor: 3.645

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.